ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effectiveness of Chinese herbal medicine combined with Western medicine on deferring dialysis initiation for nondialysis chronic kidney disease stage 5 patients: a multicenter prospective nonrandomized controlled study

Wu, Yifan; Li, Chuang; Zhang, Lei; Zou, Chuan; Xu, Peng; Wen, Zehuai; Ouyang, Wenwei; Yang, Nizhi; Zhang, Min; Lin, Qizhan; Lu, Fuhua; Wang, Lixin; Bao, Kun; Zhao, Daixin; Fu, Lizhe; Guo, Xinfeng; Yang, Lihong; Ou, Aihua; He, Zehui; Weng, Heng; Li, Jianmin; Shi, Wei; Wang, Xiaoqin; Song, Liqun; Zhan, Yongli; Sun, Wei; Wei, Lianbo; Wang, Niansong; Gui, Dingkun; Zhan, Jihong; Lu, Ying; Chen, Hongyu; Liu, Yuning; Yang, Hongtao; Chen, Ming; Wang, Yiping; Zhang, Peiqing; Deng, Yueyi; Meng, Lanfen广东省人民医院; 广州军区广州总医院; 广州中医药大学; 北京大学; 南方医科大学; 上海交通大学; 中国人民解放军第四军医大学; 6; 1
Annals of Translational Medicine2021-3DOI: 10.21037/atm-21-871
3被引6阅读
引用收藏
分享

摘要

Background: In clinical practice, Chinese herbal medicine (CHM) purportedly has beneficial therapeutic effects for chronic kidney disease (CKD), which include delaying disease progression and dialysis initiation. However, there is a lack of high-quality evidence-based results to support this. Therefore, this study aimed to evaluate the efficacy of CHM combined with Western medicine in the treatment of stage 5 CKD. Methods: This was a prospective nonrandomized controlled study. Stage 5 CKD (nondialysis) patients were recruited form 29 AAA class hospitals across China from July 2014 to April 2019. According to doctors? advice and the patients? wishes, patients were assigned to the CHM group (Western medicine + CHM) and the non-CHM group (Western medicine). Patient demographic data, primary disease, blood pressure, Chinese and Western medical drugs, clinical test results, and time of dialysis initiation were collected during follow-up. Results: A total of 908 patients were recruited in this study, and 814 patients were finally included for further analysis, including 747 patients in the CHM group and 67 patients in the non-CHM group. 482 patients in the CHM group and 52 patients in the non-CHM group initiated dialysis. The median time of initiating dialysis was 9 (7.90, 10.10) and 3 (0.98,5.02) months in the CHM group and non-CHM group, respectively. The multivariate Cox regression analysis showed that patients in the CHM group had a significantly lower risk of dialysis [adjusted hazard ratio (aHR): 0.38; 95% confidence interval (CI): 0.28, 0.53] compared to those in the non-CHM group. After 1:2 matching, the outcomes of 160 patients were analyzed. The multivariate Cox regression analysis showed that patients in the CHM group had a significantly lower risk of dialysis (aHR: 0.32; 95% CI: 0.21, 0.48) compared to patients in the non-CHM group. Also, the Kaplan-Meier analysis demonstrated that the cumulative incidence of dialysis in the CHM group was significantly lower than that in the non-CHM group (log-rank test, P<0.001) before and after matching. Conclusions: This study suggest that the combination of CHM and Western medicine could effectively reduce the incidence of dialysis and delay the time of dialysis initiation in stage 5 CKD patients. @@@ Background: In clinical practice, Chinese herbal medicine (CHM) purportedly has beneficial therapeutic effects for chronic kidney disease (CKD), which include delaying disease progression and dialysis initiation. However, there is a lack of high-quality evidence-based results to support this. Therefore, this study aimed to evaluate the efficacy of CHM combined with Western medicine in the treatment of stage 5 CKD. @@@ Methods: This was a prospective nonrandomized controlled study. Stage 5 CKD (nondialysis) patients were recruited form 29 AAA class hospitals across China from July 2014 to April 2019. According to doctors' advice and the patients' wishes, patients were assigned to the CHM group (Western medicine + CHM) and the non-CHM group (Western medicine). Patient demographic data, primary disease, blood pressure, Chinese and Western medical drugs, clinical test results, and time of dialysis initiation were collected during follow-up. @@@ Results: A total of 908 patients were recruited in this study, and 814 patients were finally included for further analysis, including 747 patients in the CHM group and 67 patients in the non-CHM group. 482 patients in the CHM group and 52 patients in the non-CHM group initiated dialysis. The median time of initiating dialysis was 9 (7.90, 10.10) and 3 (0.98,5.02) months in the CHM group and non-CHM group, respectively. The multivariate Cox regression analysis showed that patients in the CHM group had a significantly lower risk of dialysis [adjusted hazard ratio (aHR): 0.38; 95% confidence interval (CI): 0.28, 0.53] compared to those in the non-CHM group. After 1:2 matching, the outcomes of 160 patients were analyzed. The multivariate Cox regression analysis showed that patients in the CHM group had a significantly lower risk of dialysis (aHR: 0.32; 95% CI: 0.21, 0.48) compared to patients in the non-CHM group. Also, the Kaplan-Meier analysis demonstrated that the cumulative incidence of dialysis in the CHM group was significantly lower than that in the non-CHM group (log-rank test, P<0.001) before and after matching. @@@ Conclusions: This study suggest that the combination of CHM and Western medicine could effectively reduce the incidence of dialysis and delay the time of dialysis initiation in stage 5 CKD patients.

学科与关键词

关键词
Chinese herbal medicine (CHM)stage 5 chronic kidney disease (stage 5 CKD)prospective
相关
加载中…
  • Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease
    Mao Wei; Zhang Lei; Zou Chuan; Li Chuang; Wu Yifan; Su Guobin; Guo Xinfeng; Wu Yuchi; Lu Fuhua; Lin Qizhan; Wang Lixin; Bao Kun; Xu Peng; Zhao Daixin; Peng Yu; Liang Hui; Lu Zhaoyu; Gao Yanxiang; Jie Xina; Zhang La; Wen Zehuai*; Liu XushengBMC Complementary and Alternative Medicine, 2015, 15: 316.
  • Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study
    Yang, Lihong; Chen, Xueyin; Li, Chuang; Xu, Peng; Mao, Wei; Liang, Xing; Zuo, Qi; Ma, Weizhong; Guo, Xinfeng*; Bao, Kun*Frontiers in Pharmacology, 2022, 12: 760482.被引 2
  • Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine
    Qu, Yi-lun; Dong, Zhe-yi; Cheng, Hai-mei; Liu, Qian; Wang, Qian; Yang, Hong-tao; Mao, Yong-hui; Li, Ji-jun; Liu, Hong-fang; Geng, Yan-qiu; Huang, Wen; Liu, Wen-hu; Xie, Hui-di; Peng, Fei; Li, Shuang; Jiang, Shuang-shuang; Li, Wei-zhen; Duan, Shu-wei; Feng, Zhe; Zhang, Wei-guang; Liu, Yu-ning; Tian, Jin-zhou; Chen, Xiang-mei*Chinese Journal of Integrative Medicine, 2023, 29(4): 308-315.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Annals of Translational Medicine
发表日期
2021-03
卷期
第 9 卷, 第 6 期
页码
490
DOI
10.21037/atm-21-871
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Ministry of Science and Technology of the People's Republic of China [2013BAI02B04]; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine [SZ2020ZZ22]; Special Project of Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome [ZH2020KF02]

作者

  • W

    Wu, Yifan (第一作者)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Li, Chuang

    2 · guangdong prov hosp · guangzhou univ chinese med

查看全部 66 位作者收起作者
  • Z

    Zhang, Lei

  • Z

    Zou, Chuan

    2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xu, Peng

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wen, Zehuai

    2 · guangdong prov hosp · guangzhou univ chinese med

  • O

    Ouyang, Wenwei

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Y

    Yang, Nizhi

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhang, Min

    2 · guangzhou univ chinese med

  • L

    Lin, Qizhan

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Lu, Fuhua

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wang, Lixin

    2 · guangdong prov hosp · guangzhou univ chinese med

  • B

    Bao, Kun

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhao, Daixin

    2 · guangdong prov hosp · guangzhou univ chinese med

  • F

    Fu, Lizhe

    2 · guangdong prov hosp · guangzhou univ chinese med

  • G

    Guo, Xinfeng

    2 · guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • Y

    Yang, Lihong

    2 · guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • O

    Ou, Aihua

    2 · guangdong prov hosp · guangzhou univ chinese med

  • H

    He, Zehui

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Weng, Heng

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Li, Jianmin

    2 · guangdong prov hosp · guangzhou univ chinese med

  • S

    Shi, Wei

    1 · guangxi univ chinese med

  • W

    Wang, Xiaoqin

  • S

    Song, Liqun

    1 · heilongjiang univ chinese med

  • Z

    Zhan, Yongli

    guanganmen hosp

  • S

    Sun, Wei

  • W

    Wei, Lianbo

    southern med univ

  • W

    Wang, Niansong

    6 · shanghai jiao tong univ

  • G

    Gui, Dingkun

    6 · shanghai jiao tong univ

  • Z

    Zhan, Jihong

    1 · guiyang coll tradit chinese med

  • L

    Lu, Ying

  • C

    Chen, Hongyu

  • L

    Liu, Yuning

  • Y

    Yang, Hongtao

  • C

    Chen, Ming

  • W

    Wang, Yiping

  • Z

    Zhang, Peiqing

  • D

    Deng, Yueyi

  • M

    Meng, Lanfen

  • C

    Cheng, Xiaohong

  • L

    Li, Feng

  • Y

    Yu, Dajun

  • X

    Xu, Damin

  • F

    Fang, Jing'ai

  • L

    Li, Hongyan

  • F

    Fu, Junzhou

  • X

    Xie, Yuansheng

  • L

    Li, Wenge

  • Z

    Zhao, Jinghong

  • H

    Huang, Yuanhang

  • L

    Lu, Zhaoyu

    2 · guangdong prov hosp · guangzhou univ chinese med

  • S

    Su, Guobin

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhang, La

  • Q

    Qin, Xindong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xu, Yuan

    2 · guangdong prov hosp · guangzhou univ chinese med

  • P

    Peng, Yu

    2 · guangdong prov hosp · guangzhou univ chinese med

  • H

    Hou, Haijing

    2 · guangdong prov hosp · guangzhou univ chinese med

  • D

    Deng, Lili

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liu, Hui

    2 · guangdong prov hosp · guangzhou univ chinese med

  • J

    Jie, Xina

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liu, Lichang

    2 · guangdong prov hosp · guangzhou univ chinese med

  • T

    Tang, Fang

    2 · guangdong prov hosp · guangzhou univ chinese med

  • P

    Pei, Hongfei

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Li, Ping

  • M

    Mao, Wei

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Liu, Xusheng

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417